Involvement of Na+/H+ Exchanger in Hypoxia/re-oxygenation-induced Neonatal Rat Cardiomyocyte Apoptosis
Overview
Authors
Affiliations
Although increased Na(+)/H(+) exchanger type-1 (NHE-1) activity has been implicated in the pathogenesis of myocardial infarction, the role of NHE-1 in induction of apoptosis, and the potential mechanisms involved have not been fully characterized. This study tested the hypothesis that NHE-1 activity is involved in hypoxia (H)/re-oxygenation (Re)-induced cardiomyocyte apoptosis by increasing mitochondrial Ca(2+) ([Ca(2+)]m). Primary cultured neonatal rat cardiomyocytes were subjected to 4.5 h of H followed by 12 h of Re. Relative to H alone, the level of X-rhod-1 acetoxymethyl (AM)-labeled [Ca(2+)]m was increased, and the frequency of cell death (propidium iodide (PI) staining) and apoptotic cells (terminal deoxynucleotidyl transferase (TdT)-mediated-UTP nick end labeling [TUNEL]), confirmed by Annexin-V, were augmented at the end of Re, along with appearance of cytosolic cytochrome c, activation of caspase-3, and increased ratio of Bax and Bcl-2. Addition of cariporide (20 micromol/l), a well-known NHE-1 inhibitor, to cultured cells before H significantly reduced [Ca(2+)]m, the number of PI and TUNEL positive cells relative to the levels at end of Re, but did not completely eliminate these changes compared to Sham control. There was a strong trend for attenuation in increased levels of [Ca(2+)]m, and the number of PI and TUNEL positive cells when same dose of cariporide was added only at Re, but the difference in these variables did not reach significance. In contrast, the levels of [Ca(2+)]m and the number of PI and TUNEL positive cells were significantly reduced to a level comparable to Sham control when cariporide (20 micromol/l) was administered before H and during Re, respectively, associated with a reduction in cytosolic cytochrome c, caspase-3 activity and ratio of Bax and Bcl-2. In conclusion, these data suggest that NHE-1 is involved in induction of cardiomyocyte apoptosis during both H and Re through a [Ca(2+)]m-dependent manner, thereby resulting in activation of cytochrome c-caspase-3 signaling pathways.
Atrial Cardiomyopathy in Valvular Heart Disease: From Molecular Biology to Clinical Perspectives.
Molnar A, Santa A, Pasztor D, Merkely B Cells. 2023; 12(13).
PMID: 37443830 PMC: 10340254. DOI: 10.3390/cells12131796.
Son J, Gerenza A, Bingener G, Bonkowsky J Front Cell Neurosci. 2022; 16:963037.
PMID: 36212692 PMC: 9540391. DOI: 10.3389/fncel.2022.963037.
Liao W, Rao Z, Wu L, Chen Y, Li C Front Pharmacol. 2022; 13:850053.
PMID: 35747748 PMC: 9209753. DOI: 10.3389/fphar.2022.850053.
Nodari S, Fioretti F, Barilla F Heart Fail Rev. 2022; 28(3):607-625.
PMID: 35133551 PMC: 8821791. DOI: 10.1007/s10741-021-10203-9.
SGLT2i: beyond the glucose-lowering effect.
Ni L, Yuan C, Chen G, Zhang C, Wu X Cardiovasc Diabetol. 2020; 19(1):98.
PMID: 32590982 PMC: 7320582. DOI: 10.1186/s12933-020-01071-y.